瘤性腺病毒血清型35介导瘤生长抑制通过有效激活抗瘤免疫力
Ryosuke Ono1, Sora Tokuoka2, Masashi Tachibana1,2
1Laboratory of Biochemistry and Molecular Biology, Graduate School of Pharmaceutical Sciences, The University of Osaka, Osaka, Japan.
Journal for immunotherapy of cancer
|July 10, 2025
概括
瘤性腺病毒OAd35激活免疫细胞,包括自然杀手 (NK) 细胞,以抑制瘤生长. 类型I干扰子信号对于OAd35是必不可少的.
科学领域:
- 瘤治疗性病毒疗法
- 免疫瘤学 免疫瘤学
背景情况:
- 瘤性腺病毒 (OAds) 具有双重的抗瘤机制:直接瘤细胞溶解和免疫系统激活.
- 人类腺病毒血清型35 (OAd35) 是一种新型的OAd,具有已证明的杀死瘤细胞的能力.
- 需要进一步研究OAd35在激活抗瘤免疫力的作用.
研究的目的:
- 调查OAd35诱导的免疫细胞激活是否有助于其抗瘤作用.
- 评估参与OAd35治疗作用的特定免疫细胞群.
主要方法:
- 在携带瘤的免疫能力强和裸体小鼠中,对OAd35进行内注射.
- 治疗后免疫细胞透和激活的分析.
- 在免疫细胞枯竭 (asialo GM1+) 和淘汰 (IFNAR1,TLR9) 的小鼠模型中评估OAd35的疗效.
主要成果:
- OAd35治疗导致了瘤中自然杀手 (NK) 细胞和T细胞的显著透和激活.
- 亚西洛GM1+细胞 (包括NK细胞) 的枯竭会损害OAd35介导的瘤生长抑制.
- 缺少I型干扰素信号传递 (IFNAR1淘汰) 显著降低了NK细胞透,激活和OAd35的抗瘤作用.
结论:
- 免疫细胞,特别是NK细胞,在OAd35.35的抗瘤疗效中起着至关重要的作用.
- I型干扰素信号传递对于OAd35诱导的NK细胞反应和瘤生长抑制是不可或缺的.
- 通过增强抗瘤免疫活性,OAd35显示出作为癌症免疫治疗剂的巨大潜力.
相关概念视频
Tumor Immunotherapy
665
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
665
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Cytotoxic T Cells-mediated Immune Response
2.4K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
2.4K
Mechanisms of Retrovirus-induced Cancers
5.3K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.3K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K


